Sign in

CIK 0001386570

  • Large accelerated filer

Niagen Bioscience, Inc.

Sign in to watch
Ticker
NAGE
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262940963
Phone
+1 310-388-6706
Business address
10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
Former names
ChromaDex Corp., CODY RESOURCES, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-22 BLOCK STEPHEN A Director Grant or award · Stock Options (right to buy) +20,000 20,000
2018-06-22 Rubin Steven D Director Grant or award · Stock Options (right to buy) +20,000 20,000
2018-06-04 Bratkovich Lisa CHIEF MARKETING OFFICER Grant or award · Stock Option (right to buy) +200,000 200,000
2018-05-18 FARR KEVIN M CHIEF FINANCIAL OFFICER Purchase +5,000 $3.83 $19K 5,000
2018-05-17 Friedman Mark J GENERAL COUNSEL Purchase +3,000 $3.60 $11K 3,000
2018-05-16 Jaksch Frank L Jr CEO Purchase +4,300 $3.56 $15K 211,357
2018-05-15 Jaksch Frank L Jr CEO Purchase +5,500 $3.61 $20K 207,057
2018-05-15 Fried Robert N PRESIDENT, COO Purchase +10,000 $3.63 $36K 926,574
2018-05-15 Fried Robert N PRESIDENT, COO Grant or award +10,000 $3.63 $36K 926,574
2018-03-29 Jaksch Frank L Jr CEO Exercise or conversion +474 $4.50 $2K 202,031
2018-03-29 Jaksch Frank L Jr CEO Sale −474 $4.60 $2K 201,557
2018-03-29 Jaksch Frank L Jr CEO Exercise or conversion · Employee Stock Options (right to buy) −474 171,503
2018-03-27 Jaksch Frank L Jr CEO Exercise or conversion +24,578 $4.50 $111K 226,135
2018-03-27 Jaksch Frank L Jr CEO Sale −24,578 $4.60 $113K 201,557
2018-03-27 Jaksch Frank L Jr CEO Exercise or conversion · Employee Stock Options (right to buy) −24,578 171,977
2018-01-22 Friedman Mark J General Counsel Grant or award · Stock Option (right to buy) +500,000 500,000
2018-01-21 Rhonemus Troy Allen EXECUTIVE VICE PRESIDENT Grant or award · Employee Stock Options (right to buy) +120,000 120,000
2018-01-21 Fried Robert N PRESIDENT, COO, CSO Grant or award · Employee Stock Options (right to buy) +300,000 300,000
2018-01-21 Jaksch Frank L Jr CEO Grant or award · Employee Stock Options (right to buy) +50,000 50,000
2018-01-11 Jaksch Frank L Jr CEO Exercise or conversion +6,249 $4.50 $28K 207,806

Page 9 of 12 · 238 trades